A Feasibility Trial of Neoadjuvant Cisplatin-Pemetrexed with Atezolizumab in Combination and in Maintenance for Resectable Malignant Pleural Mesothelioma.

IRB/UVA Tracking #
21441
Contact
Hakeem Oufkir
Contact Email
HO8UJ@hscmail.mcc.virginia.edu
Contact Phone
Phase
I
Primary purpose
Treatment
NCT
NCT03228537
Cancer PI
Richard Hall
Status
OPEN TO ACCRUAL
Ages
Adult